Maximum-likelihood approaches reveal signatures of positive selection in IL genes in mammals

Innate Immunity

Volumn 20, Issue 2, 2014, Pages 184-191

  Neves, Fabiana ^a,b   Abrantes, Joana ^a,c   Steinke, John W ^d   Esteves, Pedro J ^a,e  

^a CENTRO DE INVESTIGAÇÃO EM BIODIVERSIDADE E RECURSOS GENÉTICOS   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITY OF VIRGINIA   (United States)

^e INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

Author keywords

IL receptors; ILs; maximum likelihood; positive selection

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 17; INTERLEUKIN 17B; INTERLEUKIN 17C; INTERLEUKIN 17F; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 1ALPHA; INTERLEUKIN 1B; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 24; INTERLEUKIN 25; INTERLEUKIN 26; INTERLEUKIN 27A; INTERLEUKIN 27B; INTERLEUKIN 29; INTERLEUKIN 34; INTERLEUKIN 36A; INTERLEUKIN 36G; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ARTICLE; CODON; CRYSTALLOGRAPHY; GENE; GENE SEQUENCE; GENOME; INTERLEUKIN GENE; MUTAGENESIS;

IL RECEPTORS; ILS; MAXIMUM LIKELIHOOD; POSITIVE SELECTION;

ANIMALS; BIOLOGICAL EVOLUTION; CODON; CRYSTALLOGRAPHY, X-RAY; GENOME; INTERLEUKINS; LIKELIHOOD FUNCTIONS; MAMMALS; MUTAGENESIS, SITE-DIRECTED; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; SOFTWARE;

EID: 84892774920     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913486687     Document Type: Article

References (62)

1. O'Connell MJ, McInerney JO. Gamma chain receptor interleukins: evidence for positive selection driving the evolution of cell-to-cell communicators in the mammalian immune system. J Mol Evol. 2005 ; 61: 608-619
2. Zelus D, Robinson-Rechavi M, Delacre M, et al. Fast evolution of interleukin-2 in mammals and positive selection in ruminants. J Mol Evol. 2000 ; 51: 234-244
3. Kaiser P, Rothwell L, Avery S, Balu S. Evolution of the interleukins. Develop Comp Immunol. 2004 ; 28: 375-394
4. Zhang J, Nei M. Positive selection in the evolution of mammalian interleukin-2 genes. Mol Biol Evol. 2000 ; 17: 1413-1416
5. Brocker C, Thompson D, Matsumoto A, et al. Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics. 2010 ; 5: 30-55
6. Poon AF, Frost SD, Pond SL. Detecting signatures of selection from DNA sequences using Datamonkey. Methods Mol Biol. 2009 ; 537: 163-183
7. Schrader JW. Interleukin is as interleukin does. J Immunol Methods. 2003 ; 276: 1-3
8. Beadling C, Slifka MK. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp (Warsz). 2006 ; 54: 15-24
9. Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011 ; 127: 701-721 e1-e70
10. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem. 2002 ; 277: 29355-29358
11. Afzal N, Tahir R, Jahan S. Cytokines: an ever expanding area. Biol Biomed Rep. 2012 ; 2: 37-43
12. Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003 ; 374: 1-20
13. Ishihara K, Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta. 2002 ; 1592: 281-296
14. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol. 2003 ; 111: S460 - S475
15. Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol. 2010 ; 125: S53 - S72
16. Steinke JW, Borish L. 3. Cytokines and chemokines. J Allergy Clin Immunol. 2006 ; 117: S441 - S445
17. Sabat R. IL-10 family of cytokines. Cytokine Growth Factor Rev. 2010 ; 21: 315-324
18. Krause CD, Pestka S. Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol Ther. 2005 ; 106: 299-346
19. Leonard WJ, Lin JX. Cytokine receptor signaling pathways. J Clin Immunol. 2000 ; 105: 877-888
20. Secombes CJ, Wang T, Bird S. The interleukins of fish. Develop Immunol. 2011 ; 35: 1336-1345
21. Fumagalli M, Pozzoli U, Cagliani R, et al. Parasites represent a major selective force for interleukins genes and shape the genetic predisposition to autoimmune conditions. J Exp Med. 2009 ; 206: 1395-1408
22. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol. 2008 ; 121: 1108-1111
23. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci. 1997 ; 2: d12 - d26
24. Haddad JJ. Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun. 2002 ; 297: 700-713
25. Barreiro LB, Quintana-Murci L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet. 2010 ; 11: 17-30
26. Koyanagi M, Kerns JA, Chung L, et al. Diversifying selection and functional analysis of interleukin-4 suggests antagonism-driven evolution at receptor-binding interfaces. BMC Evol Biol. 2010 ; 10: 223-223
27. Makalowski W, Boguski MS. Synonymous and nonsynonymous substitution distances are correlated in mouse and rat genes. J Mol Evol. 1998 ; 47: 119-121
28. PIL-lai MR, Bix M. Evolution of IL4 and pathogen antagonism. Growth Factors. 2011 ; 29: 153-160
29. Manry J, Laval G, Patin E, et al. Evolutionary genetic dissection of human interferons. J Exp Med. 2011 ; 208: 2747-2759
30. Tindall EA, Hayes VM. Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation. DNA Res. 2010 ; 17: 117-122
31. Zhou G, Zhai Y, Dong X, et al. Haplotype structure and evidence for positive selection at the human IL13 locus. Mol Biol Evol. 2004 ; 21: 29-35
32. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. 1999 ; 41: 95-98
33. Majewski J, Ott J. Amino acid substitutions in the human genome: evolutionary implications of single nucleotide polymorphisms. Gene. 2003 ; 305: 167-173
34. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci. 1997 ; 13: 555-556
35. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol. 2007 ; 24: 1586-1591
36. Kosakovsky Pond SL, Frost SD. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 2005 ; 22: 1208-1222
37. Pond SL, Frost SD. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics. 2005 ; 21: 2531-2533
38. Poon AF, Frost SD, Pond SL. Detecting signatures of selection from DNA sequences using Datamonkey. Methods Mol Biol. 2009 ; 537: 163-183
39. Bielawski JP, Yang Z. Maximum likelihood methods for detecting adaptive evolution after gene duplication. J Struct Funct Genomics. 2003 ; 3: 201-212
40. Yang Z. Inference of selection from multiple species alignments. Curr Opin Genet Dev. 2002 ; 12: 688-694
41. Yang Z, Nielsen R, Goldman N, Pedersen AM. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics. 2000 ; 155: 431-449
42. Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011 ; 28: 2731-2739
43. Areal H, Abrantes J, Esteves PJ. Signatures of positive selection in Toll-like receptor (TLR) genes in mammals. BMC Evol Biol. 2011 ; 11: 368-368
44. Wlasiuk G, Nachman MW. Adaptation and constraint at Toll-like receptors in primates. Mol Biol Evol. 2010 ; 27: 2172-2186
45. Kosiol C, Vinar T, da Fonseca RR, et al. Patterns of positive selection in six Mammalian genomes. PLoS Genet. 2008 ; 4: e1000144 - e1000144
46. Ferrer-Admetlla A, Bosch E, Sikora M, et al. Balancing selection is the main force shaping the evolution of innate immunity genes. J Immunol. 2008 ; 181: 1315-1322
47. Smith KA. The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs. Med Immunol. 2006 ; 5: 3-3
48. Hage T, Sebald W, Reinemer P. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell. 1999 ; 97: 271-281
49. LaPorte SL, Juo ZS, Vaclavikova J, et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008 ; 132: 259-272
50. Zarlenga DS, Dawson H, Kringel H, et al. Molecular cloning of the swine IL-4 receptor alpha and IL-13 receptor 1-chains: effects of experimental Toxoplasma gondii, Ascaris suum and Trichuris suis infections on tissue mRNA levels. Vet Immunol Immunopathol. 2004 ; 101: 223-234
51. Zhang JL, Simeonowa I, Wang Y, Sebald W. The high-affinity interaction of human IL-4 and the receptor alpha chain is constituted by two independent binding clusters. J Mol Biol. 2002 ; 315: 399-407
52. Mueller TD, Zhang JL, Sebald W, Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta. 2002 ; 1592: 237-250
53. Dinarello CA. Targeting interleukin 18 with interleukin 18 binding protein. Ann Rheum Dis. 2000 ; 59: i17 - i20
54. He Z, Lu L, Altmann C, et al. Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury. Am J Physiol Renal Physiol. 2008 ; 295: F1414 - F1421
55. Mallat Z, Corbaz A, Scoazec A, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 2001 ; 89: E41 - E45
56. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr. 2006 ; 83: 447S - 455S
57. Shental-Bechor D, Levy Y. Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc Natl Acad Sci USA. 2008 ; 105: 8256-8261
58. Szabo TG, Palotai R, Antal P, et al. Critical role of glycosylation in determining the length and structure of T cell epitopes. Immunome Res. 2009 ; 5: 4-4
59. Waetzig GH, Chalaris A, Rosenstiel P, et al. N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130. J Biol Chem. 2010 ; 285: 1781-1789
60. Chamorey AL, Magne N, Pivot X, MIL-ano G. Impact of glycosylation on the effect of cytokines. A special focus on oncology. Eur Cytokine Netw. 2002 ; 13: 154-160
61. Li XQ, Zhang T, Donnelly D. Selective loss of cysteine residues and disulphide bonds in a potato proteinase inhibitor II family. PLoS One. 2011 ; 6: e18615 - e18615
62. Fass D. Disulfide bonding in protein biophysics. Annu Rev Biophys. 2012 ; 41: 63-79